In the first 2 of a series of 6 new guidelines to be released this year, the American Academy of Dermatology and National Psoriasis Foundation address biologic use and comorbidities in the treatment of psoriasis.

FDA Alerts

FDA Alerts
Tuesday, January 2, 2018
The FDA has approved a generic topical solution for the treatment of chronic, moderately severe psoriasis of the scalp.
FDA Alerts
Monday, December 4, 2017
The FDA has expanded the approval of a psoriasis drug to now treat adults with psoriatic arthritis.
FDA Alerts
Monday, October 23, 2017
The FDA has approved extended use of a rheumatoid arthritis drug for the treatment of adult patients with active psoriatic arthritis or active ankylosing spondylitis.
FDA Alerts
Monday, October 16, 2017
The FDA has approved an expanded indication for ustekinumab (Stelara; Janssen) for the treatment of adolescent patients 12 years or older with moderate to severe plaque psoriasis.

News

News
Friday, October 26, 2018
A recent poster study, presented at the 2018 Fall Clinical Dermatology Conference, examined the risk of malignancy associated with biologics among patients with psoriasis.
News
Wednesday, October 24, 2018
In a recent study, researchers assessed the efficacy of a tumor necrosis factor inhibitor combined with methotrexate at achieving remission among patients with early active psoriatic arthritis.
News
Monday, October 22, 2018
Findings from a recent study highlight the destructive nature of psoriatic arthritis and the influence of age and disease duration on anabolic and catabolic bone damage.
News
Wednesday, October 17, 2018
Findings from a recent study showed potential associations between psoriasis, comorbid conditions, and sexual and erectile dysfunction among patients with this skin condition.

NPF Endorsed Articles

NPF Endorsed Articles
Monday, March 26, 2018
The studies presented at 2018 American Academy of Dermatology Annual Meeting offered dermatologists the latest research and management approaches for psoriasis.
NPF Endorsed Articles
Tuesday, February 27, 2018
The posters presented at The Winter Clinical Dermatology Conference–Hawaii showcased the latest research and management approaches for skin conditions they encounter in clinical practice.
NPF Endorsed Articles
Tuesday, December 22, 2015
Researchers conducted a systematic literature review of 73 published studies to identify factors associated with treatment non-adherence across diseases in rheumatology, gastroenterology and dermatology.   
NPF Endorsed Articles
Monday, December 21, 2015
In a study published in American Journal of Clinical Dermatology, researchers analyzed the efficacy of adalimumab (Humira, AbbVie Inc.) in patients with psoriasis who previously received systematic therapy. 

Research in Review

Research in Review
Thursday, May 17, 2018
A review of recent news, research, and treatment related to psoriasis.
Research in Review
Tuesday, February 20, 2018
A review of recent news, research, and treatment related to psoriasis
Research in Review
Tuesday, January 9, 2018
The Research Trainee Symposium brings together the sharpest minds in psoriatic disease research.
Research in Review
Tuesday, December 5, 2017
This case evaluates follicular psoriasis, an uncommon variant manifesting as scaly folliculocentric hyperkeratotic eruptions of the trunk and extremities.